Phase 2 Study of Epacadostat, Pembrolizumab, and CRS-207, With or Without Cyclophosphamide and GVAX Pancreas Vaccine in Patients With Metastatic Pancreas Cancer
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2017
At a glance
- Drugs CRS 207 (Primary) ; Cyclophosphamide (Primary) ; Epacadostat (Primary) ; Pembrolizumab (Primary) ; Tumour cell vaccine-GVAX (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2017 Planned initiation date changed from 1 Jun 2017 to 1 Sep 2017.
- 03 May 2017 Planned initiation date changed from 1 Feb 2017 to 1 Jun 2017.
- 03 Jan 2017 New trial record